Morihito Okada

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

Hisashi Saji, Morihito Okada, Masahiro Tsuboi et al. · The Lancet · 2022 · 1.7K citations

Medicine, Oncology, Surgery +13

Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study

Morihito Okada, Teruaki Koike, Masahiko Higashiyama et al. · Journal of Thoracic and Cardiovascular Surgery · 2006 · 725 citations · Full text

Medicine, Oncology, Surgery +14

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial

Haruhiro Saito, Tatsuro Fukuhara, Naoki Furuya et al. · The Lancet Oncology · 2019 · 636 citations · Full text

Medicine, Oncology, Pharmacology +12

Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial

Kenji Suzuki, Hisashi Saji, Keiju Aokage et al. · Journal of Thoracic and Cardiovascular Surgery · 2019 · 497 citations · Full text

Medicine, Clinical Sciences, Surgery +11

Appropriate Sublobar Resection Choice for Ground Glass Opacity-Dominant Clinical Stage IA Lung Adenocarcinoma

Yasuhiro Tsutani, Yoshihiro Miyata, Haruhiko Nakayama et al. · CHEST Journal · 2013 · 314 citations

Medicine, Oncology, Surgery +11